Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088881
Status:
TERMINATED
Last Update Posted:
2017-05-25
First Post:
2004-08-04
Brief Title:
Rituximab Combination Chemotherapy and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkins Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-12
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2004-08-04
First Submit QC Date:
August 4 2004
Study First Post Date:
2004-08-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-02-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-20
Last Update Post Date:
2017-05-25
Last Update Post Date Type:
ACTUAL